BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
Colorcon
Daiichi Sankyo
Federal Trade Commission
Moodys
Merck
Chinese Patent Office
Boehringer Ingelheim
Express Scripts

Generated: January 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,339,551

« Back to Dashboard

Which drugs does patent 9,339,551 protect, and when does it expire?

Patent 9,339,551 protects PENNSAID and is included in one NDA.

This patent has seventeen patent family members in fourteen countries.
Summary for Patent: 9,339,551
Title:Diclofenac topical formulation
Abstract: The present invention provides a gel formulation comprising diclofenac sodium which has superior transdermal flux properties, which may be used for the topical treatment of pain, such as in osteoarthritis.
Inventor(s): Kisak; Ed (San Diego, CA), Singh; Jagat (Toronto, CA)
Assignee: HZNP Limited (Pembroke, BM)
Application Number:14/705,593
Patent Claim Types:
see list of patent claims

Drugs Protected by US Patent 9,339,551

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Horizon Pharma PENNSAID diclofenac sodium SOLUTION;TOPICAL 204623-001 Jan 16, 2014 RX Yes Yes ➤ Subscribe ➤ Subscribe USE OF TOPICAL DICLOFENAC FOR TREATING PAIN ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents Family Members for Patent 9,339,551

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,101,591 Diclofenac topical formulation ➤ Subscribe
8,252,838 Diclofenac topical formulation ➤ Subscribe
9,220,784 Diclofenac topical formulation ➤ Subscribe
8,563,613 Diclofenac topical formulation ➤ Subscribe
9,168,304 Diclofenac topical formulation ➤ Subscribe
9,066,913 Diclofenac topical formulation ➤ Subscribe
8,871,809 Diclofenac topical formulation ➤ Subscribe
9,539,335 Diclofenac topical formulation ➤ Subscribe
9,168,305 Diclofenac topical formulation ➤ Subscribe
9,339,552 Diclofenac topical formulation ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 9,339,551

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Canada 2666398 ➤ Subscribe
China 101588791 ➤ Subscribe
China 104606126 ➤ Subscribe
Denmark 2086504 ➤ Subscribe
European Patent Office 2086504 ➤ Subscribe
European Patent Office 2626063 ➤ Subscribe
Hong Kong 1134024 ➤ Subscribe
Israel 198161 ➤ Subscribe
Japan 2010506952 ➤ Subscribe
Japan 5432716 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Julphar
Healthtrust
US Army
Boehringer Ingelheim
Baxter
Fish and Richardson
Farmers Insurance
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot